Skip to main content
. 2020 Oct 16;11:578698. doi: 10.3389/fneur.2020.578698

Table 3.

Quality assessment of the 15 studies meeting inclusion criteria.

Study Diagnostic criteria Biomarkers (MCI) Biomarkers (NC) Collection of data Cross-sectional/longitudinal data Follow-up Double-blind Use of APOSTEL
Paquet et al. (21) NINCDS-ADRDA (22) No No Prospective Cross-sectional No No No
Kesler et al. (23) Petersen Criteria (24) No No Prospective Cross-sectional No No No
Shen et al. (25) Petersen Criteria (24) No No Prospective Cross-sectional No No No
Ascaso et al. (26) Winbald (27) No No Prospective Cross-sectional No No No
Oktem et al. (28) Not mentioned No No Prospective Cross-sectional No No No
Liu D et al. (29) Petersen Criteria (24) No No Prospective Cross-sectional No No No
Gao et al. (30) Petersen Criteria (24) No No Prospective Cross-sectional No No No
Cheung et al. (31) Petersen Criteria (24) No No Prospective Cross-sectional No No No
Pillai et al. (32) NIA-AA (33) Hippocampal atrophy Non-hippocampal atrophy Prospective Cross-sectional No No Yes
Giménez Castejón et al. (34) Neurological examination and DSM-IV (35) No No Retrospective Cross-sectional No No No
Ferrari et al. (36) NIA-AA (33) No No Prospective Cross-sectional No No Yes
Uchida et al. (37) NIA-AA (33) No No Prospective Cross-sectional No No Yes
Shao et al. (38) NIA-AA (33) No No Prospective Cross-sectional No No Yes
Lad et al. (39) NINCDS-ADRD (22) No No Prospective Cross-sectional No No Yes
Almeida et al. (40) NINCDS-ADRDA (22) No No Prospective Cross-sectional No No Yes

MCI, mild cognitive impairment; NC, normal controls; MRI, magnetic resonance imaging; NINCDS-ADRD, National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer Disease and Related Disorders Association; NIA-AA, National Institutes of Health-Alzheimer's Association.

Results of this study are reported as the change in layers, and no individual values were reported.